Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jianfeng Yien Biotechnology is a Chinese biotechnology company and a subsidiary of the Zhejiang Jianfeng Group. The company specializes in the research, development, and industrialization of biological fermentation products, with a primary focus on functional enzymes and probiotics. Its flagship product is Nattokinase, a potent fibrinolytic enzyme used in cardiovascular health supplements. Jianfeng Yien operates advanced manufacturing facilities in Jinhua, Zhejiang, adhering to high-quality standards for the production of health-oriented biological ingredients. The company leverages the resources of its parent conglomerate to integrate R&D with large-scale commercial production. Their product portfolio also includes Vitamin K2 and various probiotic strains targeted at digestive and metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Jianfeng Yien Biotechnology.